» Articles » PMID: 18691604

Looking for the Role of Cannabinoid Receptor Heteromers in Striatal Function

Overview
Specialties Neurology
Pharmacology
Date 2008 Aug 12
PMID 18691604
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The introduction of two concepts, "local module" and "receptor heteromer", facilitates the understanding of the role of interactions between different neurotransmitters in the brain. In artificial cell systems, cannabinoid CB(1) receptors form receptor heteromers with dopamine D2, adenosine A2A and mu opioid receptors. There is indirect but compelling evidence for the existence of the same CB1 receptor heteromers in striatal local modules centered in the dendritic spines of striatal GABAergic efferent neurons, particularly at a postsynaptic location. Their analysis provides new clues for the role of endocannabinoids in striatal function, which cannot only be considered as retrograde signals that inhibit neurotransmitter release. Recent studies using a new method to detect heteromerization of more than two proteins, which consists of sequential BRET-FRET (SRET) analysis, has demonstrated that CB1, D2 and A2A receptors can form heterotrimers in transfected cells. It is likely that functional CB1-A2A-D2 receptor heteromers can be found where they are highly co-expressed, in the dendritic spines of GABAergic enkephalinergic neurons. The functional properties of these multiple receptor heteromers and their role in striatal function need to be determined.

Citing Articles

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Rivas-Santisteban R, Munoz A, Lillo J, Raich I, Rodriguez-Perez A, Navarro G NPJ Parkinsons Dis. 2024; 10(1):220.

PMID: 39548112 PMC: 11568119. DOI: 10.1038/s41531-024-00827-7.


Adenosine A receptor as a potential target for improving cancer immunotherapy.

Atif M, Alsrhani A, Naz F, Ullah M, Alameen A, Imran M Mol Biol Rep. 2022; 49(11):10677-10687.

PMID: 35752699 DOI: 10.1007/s11033-022-07685-7.


Class A and C GPCR Dimers in Neurodegenerative Diseases.

Caniceiro A, Bueschbell B, Schiedel A, Moreira I Curr Neuropharmacol. 2022; 20(11):2081-2141.

PMID: 35339177 PMC: 9886835. DOI: 10.2174/1570159X20666220327221830.


Allosteric Modulation of Adenosine A Receptors as a New Therapeutic Avenue.

Korkutata M, Agrawal L, Lazarus M Int J Mol Sci. 2022; 23(4).

PMID: 35216213 PMC: 8880556. DOI: 10.3390/ijms23042101.


Disrupting GPCR Complexes with Smart Drug-like Peptides.

Gallo M, Defaus S, Andreu D Pharmaceutics. 2022; 14(1).

PMID: 35057055 PMC: 8779866. DOI: 10.3390/pharmaceutics14010161.


References
1.
Rios C, Gomes I, Devi L . mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol. 2006; 148(4):387-95. PMC: 1751792. DOI: 10.1038/sj.bjp.0706757. View

2.
Muller C, Ferre S . Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders. Recent Pat CNS Drug Discov. 2008; 2(1):1-21. DOI: 10.2174/157488907779561772. View

3.
Yung K, Smith A, Levey A, Bolam J . Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur J Neurosci. 1996; 8(5):861-9. DOI: 10.1111/j.1460-9568.1996.tb01573.x. View

4.
Di Marzo V, Melck D, Bisogno T, De Petrocellis L . Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 1999; 21(12):521-8. DOI: 10.1016/s0166-2236(98)01283-1. View

5.
Baneres J, Parello J . Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol. 2003; 329(4):815-29. DOI: 10.1016/s0022-2836(03)00439-x. View